Join Medtronic at EACTS 2025 for a high-impact symposium designed for cardiac surgeons navigating an increasingly complex clinical landscape. From shifting patient demographics to evolving guidelines and rising expectations around durability, timing, and technique; today’s clinical decisions carry more weight than ever.
This is your opportunity to engage with leading surgical voices, explore forward-looking strategies, and examine how innovation, surgical techniques are reshaping the surgical standard of care.
Hall 2 60 TRANSPARENTSession description
Join Medtronic at EACTS 2025 for a high-impact symposium designed for cardiac surgeons navigating an increasingly complex clinical landscape. From shifting patient demographics to evolving guidelines and rising expectations around durability, timing, and technique; today’s clinical decisions carry more weight than ever.
This is your opportunity to engage with leading surgical voices, explore forward-looking strategies, and examine how innovation, surgical techniques are reshaping the surgical standard of care.
| Time | Topic | Faculty |
|---|---|---|
|
12:15 |
Welcome |
Prof Pieter Kappetein |
|
12:18 |
ACE 2.0 registry: first Avalus™ Ultra real-world data. |
Prof Tom Verbelen |
|
12:35 |
Beyond age and risk: what the new SAVR guidelines really mean for the heart team? |
Prof Robert Klautz |
|
12:50 |
Valve strategies in the young: TAVR first, SAVR first… or regret later? |
Mr Dincer Aktuerk |
|
13: 05 |
AVR and the grade 2/3 dilemma: Do you repair the mitral or walk away? |
Prof Omer Dzemali |
|
13:20 |
Conclusion and final remarks |
Prof Pieter Kappetein |